Resultado de búsqueda
Hace 3 días · Get a real-time TG Therapeutics, Inc. (TGTX) stock price quote with breaking news, financials, statistics, charts and more.
Hace 5 días · Stock analysis for TG Therapeutics Inc (TGTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
- 284
Hace 5 días · A high-level overview of TG Therapeutics, Inc. (TGTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Hace 3 días · TG Therapeutics Inc is a biopharmaceutical company that develops and commercializes innovative treatments for multiple sclerosis (MS) and other autoimmune diseases. The company, founded in 2012, is headquartered in New York City and has operations in the United States and Europe.
- (212) 554-4484
- 2 GANSEVOORT STREET 9TH FLOOR, NEW YORK NY, 10014
- ir@tgtxinc.com
Hace 3 días · The latest TG Therapeutics stock prices, stock quotes, news, and TGTX history to help you invest and trade smarter.
- TG Therapeutics stock has received a consensus rating of buy. The average rating score is and is based on 17 buy ratings, 2 hold ratings, and 5 sel...
- The low in the last 52 weeks of TG Therapeutics stock was 6.46. According to the current price, TG Therapeutics is 304.02% away from the 52-week low.
- The high in the last 52 weeks of TG Therapeutics stock was 35.63. According to the current price, TG Therapeutics is 55.12% away from the 52-week h...
- The 24 analysts offering price forecasts for TG Therapeutics have a median target of 26.19, with a high estimate of 70.00 and a low estimate of 5.0...
Hace 3 días · View TG Therapeutics, Inc TGTX investment & stock information. Get the latest TG Therapeutics, Inc TGTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Hace 5 días · According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for TG Therapeutics is $29.83, with a high forecast of $49.00 and a low forecast of $13.00. The consensus rating for TG Therapeutics stock is Moderate Buy based on the current 1 hold rating and 5 buy ratings ...
